Biotech

All Articles

BMS trenches TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge wager from the Caforio era, canceling a bargain fo...

Nuvation stops wager prevention after considering period 1 information

.After checking out at stage 1 data, Nuvation Biography has actually made a decision to stop work wi...

' Medical intuition' led FDA consultants to back Zevra's rare disease med

.Zevra Therapeutics' unusual condition drug seems to become on the road to permission this loss afte...

Pfizer takes $230M struck after axing neglected DMD gene treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has actually blown a $230...

AC Immune observes 'spots' possible in Alzheimer's drug records

.After more than two decades of deal with neurodegenerative ailments, Swiss biotech air conditioning...

GSK falls ph. 2 HPV vaccine over shortage of best-in-class potential

.GSK has junked a phase 2 human papillomavirus (HPV) vaccination coming from its own pipeline after ...

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.OS Therapies will definitely detail on the NYSE American supply exchange today by means of a $6.4 t...

ALX's waning CD47 feedback fee sends out stock spiraling down

.ALX Oncology's stage 2 gastric cancer action rate has compromised. After finding its CD47 blocker q...

Ionis centers eye ailment coming from targets of Roche-partnered prospect after data disappoint

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has disappointed expectations, cu...

Biogen's chief executive officer said no dangerous handle 2023. He prepares to be bold

.While Biogen's pharma peers are actually seeking for late-stage assets along with little bit of ris...